Pressure Mounts for Greater Clinical Trial Data Transparency | Pharmaceutical Executive

"...A report from the non-profit Bioethics International finds that for a group of new drugs approved by FDA in 2012, large pharma companies fell “below legal and ethical standards” for making public information from the relevant clinical trials. This disappointing performance raises important ethical issues about patients’ rights in clinical research, the authors state, and could undermine the adoption of personalized and evidence-based medicine...."

For the full report on the lack of transparency and openness in clinical trials and the pharmaceutical industry, and ideas for the future, read the full article.